Evaluation of the immune responses of biological adjuvant bivalent vaccine with three different insertion modes for ND and IBD

References

• Hu ZL, He XZ, Deng J, et al. Current situation and future direction of Newcastle disease vaccines. Vet Res. 2022;53(1):99. doi: 10.1186/s13567-022-01118-w
   PubMed Web of Science ®Google Scholar
• Lupini C, Felice V, Silveira F, et al. Comparative in vivo pathogenicity study of an ITA genotype isolate (G6) of infectious bursal disease virus. Transbound Emerg Dis. 2020;67(2):1025–16. doi: 10.1111/tbed.13421
   PubMed Web of Science ®Google Scholar
• Liu YQ, Sun CX, Chi MM, et al. Genetic characterization and phylogenetic analysis of Newcastle disease virus from China. Infect Genet Evol. 2019;75:103958. doi: 10.1016/j.meegid.2019.103958
   PubMed Web of Science ®Google Scholar
• Choi KS. Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines. Clin Exp Vaccine Res. 2017;6(2):72–82. doi: 10.7774/cevr.2017.6.2.72
   PubMed Web of Science ®Google Scholar
• Duan Z, Xu H, Ji X, et al. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases. Future Microbiol. 2015;10(8):1307–1323. doi: 10.2217/FMB.15.59
   PubMed Web of Science ®Google Scholar
• De Swart RL, Belov GA. Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines. Curr Opin Virol. 2023;62:101348. doi: 10.1016/j.coviro.2023.101348
   PubMed Web of Science ®Google Scholar
• Warner BM, Chan M, Tailor N, et al. Mucosal vaccination with a Newcastle disease virus-vectored vaccine reduces viral loads in SARS-CoV-2-infected cynomolgus macaques. Vaccines (Basel). 2024;12(4):404. doi: 10.3390/vaccines12040404
   PubMed Web of Science ®Google Scholar
• Slamanig S, Gonzalez-Dominguez I, Chang LA, et al. Intranasal SARS-CoV-2 omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. EBioMedicine. 2024;105:105185. doi: 10.1016/j.ebiom.2024.105185
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang ZY, Zsak L, et al. P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression. J Gen Virol. 2015;96(1):40–45. doi: 10.1099/vir.0.068437-0
   PubMedGoogle Scholar
• Zhang ZY, Zhao W, Li DS, et al. Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism. J Gen Virol. 2015;96(8):2028–2035. doi: 10.1099/vir.0.000142
   PubMedGoogle Scholar
• Li GP, Kuang HY, Guo HX, et al. Development of a recombinant VP2 vaccine for the prevention of novel variant strains of infectious bursal disease virus. Avian Pathol. 2020;49(6):557–571. doi: 10.1080/03079457.2020.1791314
   PubMed Web of Science ®Google Scholar
• Huang ZH, Elankumaran S, Yunus AS, et al. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol. 2004;78(18):10054–10063. doi: 10.1128/JVI.78.18.10054-10063.2004
   PubMed Web of Science ®Google Scholar
• Guo XC, Sun WY, Wei L, et al. Development and evaluation of a recombinant VP2 neutralizing epitope antigen vaccine candidate for infectious bursal disease virus. Transbound Emerg Dis. 2021;68(6):3658–3675. doi: 10.1111/tbed.13974
   PubMed Web of Science ®Google Scholar
• Hamilton JA. GM-CSF in inflammation. J Exp Med. 2020;217(1):e20190945. doi: 10.1084/jem.20190945
   PubMed Web of Science ®Google Scholar
• Petrina M, Martin J, Basta S. Granulocyte macrophage colony-stimulating factor has come of age: from a vaccine adjuvant to antiviral immunotherapy. Cytokine Growth F R. 2021;59:101–110. doi: 10.1016/j.cytogfr.2021.01.001
   PubMed Web of Science ®Google Scholar
• Guo XC, Zheng Q, Jiang XH, et al. The composite biological adjuvants enhance immune response of porcine circovirus type 2 vaccine. Vet Microbiol. 2019;228:69–76. doi: 10.1016/j.vetmic.2018.11.015
   PubMed Web of Science ®Google Scholar
• Guo XC, Zhang T, Wang XX, et al. The immune enhancement effects of recombinant NDV expressing chicken granulocyte-macrophage colony stimulating factor on the different avian influenza vaccine subtypes. Transbound Emerg Dis. 2020;67(5):2108–2117. doi: 10.1111/tbed.13559
   PubMed Web of Science ®Google Scholar
• Zhang TY, Liu YY, Wang H, et al. Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody. Vet Microbiol. 2016;196:107–117. doi: 10.1016/j.vetmic.2016.10.008
   PubMed Web of Science ®Google Scholar
• Shirvani E, Paldurai A, Manoharan VK, et al. A recombinant Newcastle disease virus (NDV) expressing S protein of infectious bronchitis virus (IBV) protects chickens against IBV and NDV. Sci Rep. 2018;8(1):11951. doi: 10.1038/s41598-018-30356-2
   PubMedGoogle Scholar
• Sun WY, Cao XL, Wang YX, et al. Development and evaluation of a bivalent vaccine based on recombinant Newcastle disease virus expressing infectious bursal disease virus VP2L-CH3-CH4 in SPF chickens. Vet Microbiol. 2024;288:109950. doi: 10.1016/j.vetmic.2023.109950
   PubMed Web of Science ®Google Scholar
• Fulber JPC, Kamen AA. Development and scalable production of Newcastle disease virus-vectored vaccines for human and veterinary use. Viruses-Basel. 2022;14(5):975. doi: 10.3390/v14050975
   PubMed Web of Science ®Google Scholar
• Yan Y, Liu S, Li M, et al. Recombinant Newcastle disease virus expressing human ifn-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways. Thorac Cancer. 2018;9(11):1437–1452. doi: 10.1111/1759-7714.12857
   PubMed Web of Science ®Google Scholar
• Olszewska-Tomczyk M, Dolka I, Swieton E, et al. Genetic changes in pigeon paramyxovirus type-1 induced by serial passages in chickens and microscopic lesions caused by the virus in various avian hosts. J Vet Res. 2018;62(4):447–455. doi: 10.2478/jvetres-2018-0059
   PubMed Web of Science ®Google Scholar
• He L, Zhang ZY, Yu QZ. Expression of two foreign genes by a Newcastle disease virus vector from the optimal insertion sites through a combination of the ITU and IRES-dependent expression approaches. Front Microbiol. 2020;11:769. doi: 10.3389/fmicb.2020.00769
   PubMed Web of Science ®Google Scholar
• Wang Y, Ge JY, Xie XD, et al. Impact of modification of cleavage site of fusion protein and foreign gene insertion on the virulence of Newcastle disease virus LaSota vaccine strain. Acta Microbiologica Sin. 2008;48(3):362–368.
   PubMedGoogle Scholar
• Carnero E, Li W, Borderia AV, et al. Optimization of human immunodeficiency virus gag expression by Newcastle disease virus vectors for the induction of potent immune responses. J Virol. 2009;83(2):584–597. doi: 10.1128/JVI.01443-08
   PubMed Web of Science ®Google Scholar
• Müller H, Mundt E, Eterradossi N, et al. Current status of vaccines against infectious bursal disease. Avian Pathol. 2012;41(2):133–139. doi: 10.1080/03079457.2012.661403
   PubMed Web of Science ®Google Scholar
• S DEY, Pathak DC, Ramamurthy N, et al. Infectious bursal disease virus in chickens: prevalence, impact, and management strategies. Vet Med-Res Rep. 2019;10:85–97. doi: 10.2147/VMRR.S185159
   Web of Science ®Google Scholar
• Gimeno IM, Schat KA. Virus-induced immunosuppression in chickens. Avian Dis. 2018;62(3):272–285. doi: 10.1637/11841-041318-Review.1
   PubMed Web of Science ®Google Scholar
• Qiao QL, Song MZ, Song CC, et al. Single-dose vaccination of recombinant chimeric Newcastle disease virus (NDV) LaSota vaccine strain expressing infectious bursal disease virus (IBDV) VP2 gene provides full protection against genotype VII NDV and IBDV challenge. Vaccines (Basel). 2021;9(12):1483. doi: 10.3390/vaccines9121483
   PubMed Web of Science ®Google Scholar
• Zeshan B, Mushtaq MH, Wang XL, et al. Protective immune responses induced by in ovo immunization with recombinant adenoviruses expressing spike (S1) glycoprotein of infectious bronchitis virus fused/co-administered with granulocyte-macrophage colony stimulating factor. Vet Microbiol. 2010;148(1):8–17. doi: 10.1016/j.vetmic.2010.08.003
   PubMed Web of Science ®Google Scholar